Triastek’s Co-Development Agreement with Sperogenix Therapeutics

Morrison & Foerster LLP advised Triastek, Inc. on the deal.Triastek, Inc., a leading pharmaceutical company specializing in 3D printing of drug products, announced its co-development agreement…

This content is for Standard 1 Year members only.
Login Join Now
Sonia Carcano

Author: Sonia Carcano

This content is for Standard 1 Year members only.
Login Join Now